Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00162) | |||||
---|---|---|---|---|---|
Name |
Dabigatran etexilate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
BIBR 1048; UNII-2E18WX195X; BIBR 1048 BS RS1; 2E18WX195X; (E)-ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; Hexyl 2-(4-(((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)benzylidene)hydrazinecarboxylate; CHEMBL539697; GTPL6379; DTXSID4057681; HMS3744O05; MFCD16038312; AKOS015951090; Dabigatran etexilate [USAN:INN:BAN]; CCG-270280; CS-0530; DB06695; SB19225; AC-22314; AK-68186; HY-10274; DB-066446; FT-0650701; EC 606-722-8; 1019206-66-6; beta-Alanin,N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-ethylester; Ethyl 3-(((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate; ethyl 3-(1-{2-[({4-[amino({[(hexyloxy)carbonyl]imino})methyl]phenyl}amino)methyl]-1-methyl-1H-1,3-benzodiazol-5-yl}-N-(pyridin-2-yl)formamido)propanoate; ethyl 3-[[2-[[[4-(N'-hexoxycarbonylcarbamimidoyl)phenyl]amino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate; Ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Venous thromboembolism | ICD-11: BD72 | [1] | ||
PubChem CID | |||||
Formula |
C34H41N7O5
|
||||
Canonical SMILES |
CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4
|
||||
InChI |
1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)
|
||||
InChIKey |
KSGXQBZTULBEEQ-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=135565674"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 627.7 | Topological Polar Surface Area | 152 | |
XlogP | 5.3 | Complexity | 991 | ||
Heavy Atom Count | 46 | Rotatable Bond Count | 18 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Dabigatran etexilate 150 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butyl alcohol; Fd&c blue no. 2; Fd&c yellow no. 6; Isopropyl alcohol; Potassium chloride; Tartaric acid; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Water; Acacia; Alcohol; Carrageenan; Dimethicone; Hydroxypropyl cellulose; Hypromelloses; Methyl alcohol; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Potassium chloride | DIG Info | Carbonic anhydrase IV (Ki = 90000 nM) | [4] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Dabigatran Etexilate Mesylate eq 110mg base capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acacia; Dimethicone; Hypromellose; Hydroxypropyl Cellulose; Talc; Tartaric Acid; Carrageenan; Hypromellose; Potassium Chloride; Titanium Dioxide; Black Edible Ink; Fd&C Blue No. 2
|
|||||
Dosage Form | Capsule | |||||
Company | Boehringer Ingelheim | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Potassium chloride | DIG Info | Carbonic anhydrase IV (Ki = 90000 nM) | [4] | |||
Hydroxypropyl cellulose | DIG Info | Mephenytoin 4-hydroxylase (EC50 = 89.5 uM) | [7] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [7] | |||
Dabigatran Etexilate Mesylate eq 150mg base capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acacia; Dimethicone; Hypromellose; Hydroxypropyl Cellulose; Talc; Tartaric Acid; Carrageenan; Hypromellose; Potassium Chloride; Titanium Dioxide; Black Edible Ink; Fd&C Blue No. 2
|
|||||
Dosage Form | Capsule | |||||
Company | Boehringer Ingelheim | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
Potassium chloride | DIG Info | Carbonic anhydrase IV (Ki = 90000 nM) | [4] | |||
Hydroxypropyl cellulose | DIG Info | Mephenytoin 4-hydroxylase (EC50 = 89.5 uM) | [7] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [7] | |||
Dabigatran Etexilate Mesylate eq 75mg base capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acacia; Dimethicone; Hypromellose; Hydroxypropyl Cellulose; Talc; Tartaric Acid; Carrageenan; Hypromellose; Potassium Chloride; Titanium Dioxide; Black Edible Ink
|
|||||
Dosage Form | Capsule | |||||
Company | Boehringer Ingelheim | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Potassium chloride | DIG Info | Carbonic anhydrase IV (Ki = 90000 nM) | [4] | |||
Hydroxypropyl cellulose | DIG Info | Mephenytoin 4-hydroxylase (EC50 = 89.5 uM) | [7] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.